Who
Peter Rahmer
Officer
Company insider
Files Form 4 as: Officer, Relay Therapeutics.
In numbers
- Trades disclosed
- 64
- Buys
- 0
- Sells
- 41
- Bought
- $0
- Sold
- $4.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 17 Jan 2023
- Last trade
- 26 Aug 2026
- Last filed
- 28 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Aug 2026filed 28 Aug 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $90K4,508 at $20.03 | filing |
| 26 Aug 2026filed 28 Aug 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $90K4,508 at $20.03 | filing |
| 28 Jul 2026filed 30 Jul 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $14K748 at $18.61 | filing |
| 28 Jul 2026filed 30 Jul 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $14K748 at $18.61 | filing |
| 30 Jun 2026filed 2 Jul 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $955K50,000 at $19.09 | filing |
| 30 Jun 2026filed 2 Jul 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Code A | $21K3,056 at $6.95 | filing |
| 30 Jun 2026filed 2 Jul 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $955K50,000 at $19.09 | filing |
| 30 Jun 2026filed 2 Jul 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Code A | $21K3,056 at $6.95 | filing |
| 28 Apr 2026filed 30 Apr 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $11K753 at $14.79 | filing |
| 28 Apr 2026filed 30 Apr 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $11K753 at $14.79 | filing |
| 28 Jan 2026filed 29 Jan 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $11K1,354 at $8.45 | filing |
| 28 Jan 2026filed 29 Jan 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $11K1,354 at $8.45 | filing |
| 27 Jan 2026filed 29 Jan 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $89K11,684 at $7.62 | filing |
| 27 Jan 2026filed 29 Jan 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $89K11,684 at $7.62 | filing |
| 13 Jan 2026filed 15 Jan 2026 | RLAY Relay Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —475,000 at $0.00 | filing |
| 13 Jan 2026filed 15 Jan 2026 | RLAY Relay Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —475,000 at $0.00 | filing |
| 31 Dec 2025filed 29 Jan 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Code A | $2,972994 at $2.99 | filing |
| 31 Dec 2025filed 29 Jan 2026 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Code A | $2,972994 at $2.99 | filing |
| 29 Oct 2025filed 30 Oct 2025 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $160K21,394 at $7.50 | filing |
| 28 Oct 2025filed 30 Oct 2025 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $139K19,135 at $7.29 | filing |
News
Head-To-Head Comparison: Krystal Biotech (NASDAQ:KRYS) and Relay Therapeutics (NASDAQ:RLAY)RLAY · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name Peter Rahmer; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.